Emerging drug profile: menin inhibitors in NPM1-mutated and KM2A-rearranged acute myeloid leukemia. Agarwal G, Tonk RK, Sangwan K. Leuk Lymphoma 2026 May 27:1-17. doi: 10.1080/10428194.2026.2674818.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Agarwal G, Tonk RK, Sangwan K. Emerging drug profile: menin inhibitors in NPM1-mutated and KM2A-rearranged acute myeloid leukemia. Leuk Lymphoma 2026 May 27:1-17. doi: 10.1080/10428194.2026.2674818.
PMID: 42200794